Gland Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchange that the trading window for its securities has been closed in line with SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, designated persons including directors, key managerial personnel, and connected individuals are prohibited from buying or selling the company's shares. This is a routine compliance measure typically enforced ahead of a board meeting or the announcement of financial results.
This is a standard regulatory filing and does not directly affect shareholders. However, a trading window closure often signals that a material announcement — such as quarterly financial results or a significant corporate decision — may be made shortly.